Annual SG&A
$62.58 M
+$3.04 M+5.11%
31 December 2023
Summary:
Sutro Biopharma annual selling, general & administrative expenses is currently $62.58 million, with the most recent change of +$3.04 million (+5.11%) on 31 December 2023. During the last 3 years, it has risen by +$6.58 million (+11.75%). STRO annual SG&A is now at all-time high.STRO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$14.33 M
+$1.96 M+15.84%
30 September 2024
Summary:
Sutro Biopharma quarterly selling, general & administrative expenses is currently $14.33 million, with the most recent change of +$1.96 million (+15.84%) on 30 September 2024. Over the past year, it has dropped by -$2.47 million (-14.72%). STRO quarterly SG&A is now -14.72% below its all-time high of $16.80 million, reached on 31 December 2023.STRO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.56 B
-$123.95 M-5.09%
30 September 2024
Summary:
Sutro Biopharma TTM selling, general & administrative expenses is currently -$2.56 billion, with the most recent change of -$123.95 million (-5.09%) on 30 September 2024. Over the past year, it has dropped by -$2.62 billion (-4185.86%). STRO TTM SG&A is now -2123.35% below its all-time high of $62.58 million, reached on 31 December 2023.STRO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STRO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -14.7% | -4185.9% |
| 3 y3 years | +11.8% | -9.1% | -4665.9% |
| 5 y5 years | +92.0% | +64.8% | -7945.8% |
STRO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +11.8% | -14.7% | +15.8% | -122.1% | at low |
| 5 y | 5 years | at high | +92.0% | -14.7% | +65.8% | -265.8% | at low |
| alltime | all time | at high | +322.4% | -14.7% | +254.6% | -2123.3% | at low |
Sutro Biopharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $14.33 M(+15.8%) | $56.23 M(-1.6%) |
| June 2024 | - | $12.37 M(-2.8%) | $57.16 M(-4.4%) |
| Mar 2024 | - | $12.72 M(-24.3%) | $59.79 M(-4.5%) |
| Dec 2023 | $62.58 M(+5.1%) | $16.80 M(+10.1%) | $62.58 M(+3.4%) |
| Sept 2023 | - | $15.27 M(+1.8%) | $60.50 M(+1.0%) |
| June 2023 | - | $15.00 M(-3.3%) | $59.87 M(-0.2%) |
| Mar 2023 | - | $15.51 M(+5.4%) | $60.02 M(+0.8%) |
| Dec 2022 | $59.54 M(+6.3%) | $14.72 M(+0.5%) | $59.54 M(-1.7%) |
| Sept 2022 | - | $14.64 M(-3.3%) | $60.59 M(-3.1%) |
| June 2022 | - | $15.14 M(+0.7%) | $62.53 M(+4.3%) |
| Mar 2022 | - | $15.04 M(-4.6%) | $59.94 M(+7.0%) |
| Dec 2021 | $56.00 M(+52.1%) | $15.76 M(-5.0%) | $56.00 M(+10.6%) |
| Sept 2021 | - | $16.59 M(+32.2%) | $50.62 M(+17.4%) |
| June 2021 | - | $12.54 M(+12.9%) | $43.11 M(+10.0%) |
| Mar 2021 | - | $11.11 M(+7.0%) | $39.21 M(+6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $36.82 M(+13.0%) | $10.38 M(+14.4%) | $36.82 M(+4.8%) |
| Sept 2020 | - | $9.08 M(+5.0%) | $35.13 M(+2.8%) |
| June 2020 | - | $8.64 M(-0.8%) | $34.17 M(+1.7%) |
| Mar 2020 | - | $8.71 M(+0.2%) | $33.59 M(+3.1%) |
| Dec 2019 | $32.59 M(+52.4%) | $8.70 M(+7.1%) | $32.59 M(+3.6%) |
| Sept 2019 | - | $8.12 M(+0.6%) | $31.47 M(+9.6%) |
| June 2019 | - | $8.07 M(+4.6%) | $28.71 M(+16.3%) |
| Mar 2019 | - | $7.71 M(+1.9%) | $24.68 M(+15.4%) |
| Dec 2018 | $21.38 M(+30.6%) | $7.57 M(+41.5%) | $21.38 M(+19.6%) |
| Sept 2018 | - | $5.35 M(+32.4%) | $17.87 M(+2.6%) |
| June 2018 | - | $4.04 M(-8.5%) | $17.42 M(+30.2%) |
| Mar 2018 | - | $4.41 M(+8.5%) | $13.38 M(+49.2%) |
| Dec 2017 | $16.37 M(+10.5%) | $4.07 M(-16.9%) | $8.96 M(+83.1%) |
| Sept 2017 | - | $4.89 M | $4.89 M |
| Dec 2016 | $14.82 M | - | - |
FAQ
- What is Sutro Biopharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Sutro Biopharma?
- What is Sutro Biopharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Sutro Biopharma?
- What is Sutro Biopharma quarterly SG&A year-on-year change?
- What is Sutro Biopharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Sutro Biopharma?
- What is Sutro Biopharma TTM SG&A year-on-year change?
What is Sutro Biopharma annual selling, general & administrative expenses?
The current annual SG&A of STRO is $62.58 M
What is the all time high annual SG&A for Sutro Biopharma?
Sutro Biopharma all-time high annual selling, general & administrative expenses is $62.58 M
What is Sutro Biopharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of STRO is $14.33 M
What is the all time high quarterly SG&A for Sutro Biopharma?
Sutro Biopharma all-time high quarterly selling, general & administrative expenses is $16.80 M
What is Sutro Biopharma quarterly SG&A year-on-year change?
Over the past year, STRO quarterly selling, general & administrative expenses has changed by -$2.47 M (-14.72%)
What is Sutro Biopharma TTM selling, general & administrative expenses?
The current TTM SG&A of STRO is -$2.56 B
What is the all time high TTM SG&A for Sutro Biopharma?
Sutro Biopharma all-time high TTM selling, general & administrative expenses is $62.58 M
What is Sutro Biopharma TTM SG&A year-on-year change?
Over the past year, STRO TTM selling, general & administrative expenses has changed by -$2.62 B (-4185.86%)